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One hundred twenty one patients with primary hepatolithiasis (PHL) 
was encountered for the last 7 years. In order to elucidate how to 
follow and treat PHL, PHL was classified into five types (I-V) on the 
basis of morphological findings obtained by CT. It depends mainly on 
the presence of atrophy of hepatic parenchyma (AHP) and dilatation 
of intrahepatic bile ducts (DIBD). 
Methods of treatment were selected for each patient according to the 
classification. 
Type I patients comprised of 43.8% in observation group. These 
patient were asymptomatic and just followed since neither APH nor 
DIBD were observed. 
The remaining patients in the observation group, operation was 
refused or contraindicated. Most of them were asymptomatic. 
Surgical treatments were done on 47 patients (hepatic resection in 32 
patients, surgical lithotomy in 10 and others in 5). In Type III, IV and 
V, hepatic resection was often performed to remove all of stones and 
bile stasis since improvement in hepatic function could not be 
expected in view of AHP. 
All patients were followed-up 79 months or less. 
In the surgically terated patients, recurrence was not observed. In 
observation group, no new symptome developed during the follow-up 
period. 
It was suggested, therefore, that the present classification of PHL was 
helpful in determining therapeutic strategy for PHL.
I. Introduction 
Primary hepatolithiasis (PHL) is the most refractory and 
complicated condition among the various benign biliary 
tract diseases. There are still controversies on therapeutic 
choice for PHL. 
 Recently, exact conditions of the liver in PHL has been 
diagnosed by computed tomograpy (CT), which also con-
tributed to detect asymptomatic PHL. 
 PHL was classified, on the basis of morphological find-
ings obtained by CT, atrophy of hepatic parenchyma in 
particular. 
 In this study, we report that this classification of PHL is
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helpful in determining therapeutic strategy for PHL.
II. Patients and Methods 
A total of 121 patients with PHL encountered at our 
hospital between June, 1985 and December, 1991. 
 Plain CT and CT cholangiography were performed using 
a Toshiba 70A initially with a slice width of 1.0cm and 
then with a width of 0.5-1.0cm at sites showing stones. 
 PHL was classified into five types (Type I-V) by CT. 
 The classification on depends mainly on the presence of 
atrophy of hepatic parenchyma (AHP) and dilatation of 
intrahepatic bile ducts (DIBD) (Table. 1) (Fig. 1-5). 
 Type I comprised cases without AHP or DIBD, in which 
small stones were found in the periphery of intrahepatic 
bile ducts (53 patients). 
 Type II comprised cases without AHP but with DIBD 
(12 patients). 
 Type III comprised cases with AHP but without DIBD 
(8 patients). 
 Type IV comprised cases with moderate AHP and DIBD 
(25 patients). 
 Type V comprised cases with severe AHP and marked 
DIBD, in which major and peripheral bile ducts were filled 
with large stones (23 patients). 
 The intrahepatic type confined to the liver (type I) was 
observed in 90 patients, and the intrahepatic predominant 
type showing more intrahepatic than extrahepatic stones 
(type IE) in 31, which classification has been followed the 
rules proposed by the Reseach Group for the Study of 
Damage to Intrahepatic Bile Ducts.' 2> Intrahepatic stones 
were located in the right lobe alone in 49 patients (40.5%), 
left lobe alone in 62 (51.2%), and both lobes in the other 10 
(8.3%) (Table 1). 
 Methods of treatment for PHL were selected for each 
patient according to this calssification (Table 2). 
  In Type I, most of these patients were asymptomatic and 
they were not treated but just followed, since neither APH
Table 1. Classification of PHL and Patient Distribution according to Findings of CT
           Classification Patient distribution 
                                         No. of Location of stones    T
ype APH DIBD                                     Patients                               I IE R RL L 
    I (-) (-) 53 51 2 38 2 13 
    I I (-) (+) 12 7 5 2 0 10 
   III (+) (-) 8 6 2 5 0 3 
   IV (+) (+) 25 12 13 0 5 20
    V (++) (+-++) 23 14 9 4 3 16 
            Total 121 90 31 49 10 62 
APH: Atrophy of Hepatic Parenchyma 
DIBD: Dilatation of Intrahepatic Bile Ducts 
1: Intrahepatic bile ducts 
IE: Intrahepatic > Extrahepatic bile ducts 
R: Right lobe of the liver 
RL: Right and Left lobes of the liver 
L: Left lobe of the liver
Fig. 1. Classification of PHL, Type I Fig. 2. Classification of PHL, Type II
Fig. 3. Classification of PHL, Type III Fig. 4. Classification of PHL, Type IV
Fig. 5. Classification of PHL, Type V
lithotripsy under cholangioscopic guidance via an extrernal 
bile duct fistula and percutaneous transhepatic cholangio-
scopic lithotomy (PTCSL). 
 In Type III, IV and V showing liver atrophy, hepatic 
resection was performed in 30 patients, to remove of all of 
stones since improvement of hepatic function could not be 
expected in view of hepatic parenchymal atrophy, and the 
other 8 in whom the function of the remaining liver was 
decreased due to multiple operations were treated by liver-
preserving operation. 
 Thus, hepatectomy was performed in 32 of the 47 
patients treated (68.1%), liver-preserving operation in 10, 
and endoscopic removal of stones in the other 5. Stones in 
intrahepatic bile ducts were completely removed by sur-
gical and/or endoscopic procedures.
nor DIED were observed. 
 In Type II, APH was not found, so that improvement of 
liver function could be expected by removal stones and bile 
stasis. Of the patients with type II, 2 showing stones only in 
the left lobe were treated by left lateral segmentevtomy for 
complete removal of stones, 2 by choledochojejunostomy 
for extrahepatic bile duct dilatation, and the other 4 by
III. Results 
The mean observation period was 39.3 months in the 
untreated patients, 28 months in the patients treated by 
PTCSL, 34.6 months in those treated by liver-preserving 
operation and 34.5 months in those treated by hepatectomy 
(Table 3).
Table 2. Choice of Treatment for PHL according to the Classification
                                                                          Procedures of treatment 
       Type No. of patients Observation only 
                                                     PTCSL Hepatectomy (-) Hepatectomy (+) 
       I 53 53 0 0 0 
      II 12 4 4 2 2
      III 8 5 0 1 2
      IV 25 6 1 4 14
      V 23 6 0 3 14
     Total 121 74 5 10 32
PTCSL: Percutaneous Transhepatic Cholangiofiberscopic Lithotripsy
Table 3. Results of the Patients with PHL
     Choice of treatments No. of patients Follow-up periods (mos) Results 
      Observation Cholangitis (4) 
      only 74 66.5 (5.0-79.0) Death (6*) 
                                                                       Bile leak (2)
      PTCSL 5 39.8 (4.0-63.0) Death (1**)
                                                                          Cholangitis (1) 
      Hepatectomy (-) 10 50.8 (4.0-75.0) Death (2***)
      Hepatectomy (+) 32 49.6 (3.0-73.0) Death (2****) 
() No. of Patients * Cause of death 
     Bile duct ca.(1), Renal ca.(1), Lung ca.(1), Adult T-cell Leucamia (1), Esophageal ca.(1), Heart failure (1) 
** Cause of death 
    Hepatic failure (1) 
* * * Cause of death 
     Intrahepatic bile duct ca.(1), Gall bladder ca.(1) 
* * * *: Cause of death 
    Bile duct ca.(1), suicide (1)
 As postoprative complications in the treated group, a 
transient bile leakage was observed in 2 patients and cho-
langitis in 1 treated by liver-preserving operation with 
additional operation on the bile duct. Causes of death were 
intrahepatic bile duct cancer in 2 patients, gallbladder 
cancer in 1 and suicide in 1, but all the others had favorable 
postoperative courses and resumed ordinary lives. Recur-
rence was not observed. 
  In the group observed without treatment, 1 each died of 
bile duct cancer, renal cancer, lung cancer, esophageal 
cancer, adult T-cell leucemia, hepatic failure and renal 
failure. Four patients developed symptoms of gallstones 
due to falling of stones to the extrahepatic bile duct or other 
factors and underwent removal of stones.
IV. Discussion 
PHL was considered to be intractable because localization 
of stones was difficult to diagnosis, and their complete 
removal was impossible. However, recent advances in 
imaging techniques, especially CT and US, have allowed 
detection of many cases of asymptomatic intrahepatic 
stones (especially, peripheral intrahepatic bile duct type).') 
  Various classifications have been proposed for PHL,Z 3,4) 
mostly according to the site of stones. We classified PHL 
into five according to the morphology of the liver, espe-
cially liver atrophy, and selected different treatment meth-
ods according to the disease types. It was thought that Type 
I was the early stage of PHL, Type V the late stage. 
  Patients with type I were observed without treatment 
because most of them were asymptomatic and showed no 
AHP or DIBD. 
  In patients with type II who showed DIED but not AHP, 
the liver was preserved, and stones were completely re-
moved by methods such as PTCSL. 
  Patients with type III, IV, or V showing AHP, especially 
those with stones in one lobe alone were actively treated by 
hepatectomy. 
  Hepatectomy for intrahepatic stones has been considered 
to be indicated in patients with liver atrophy and stenosis or 
cystic dilatation of the intrahepatic bile duct However, 
with recent advances in endoscopic removal of stones and 
the development of non-operative techniques such as re-
lease of bile duct stenosis, the treatment modalities for 
intrahepatic stones including indications for hepatectomy 
have been changed. 
  In case 1 showing AHP, fibrosis was observed in the 
hepatic parenchyma, and hepatocytes were rarely present 
(Fig. 6). The viability of the liver was lost. It was consid-
ered that complete removal of stones may only result in the 
formation of a diverticulum in which bile, produced anoth-
er sites and regurgitated, stagnates. Therefore, hepatectomy 
was performed. CT cleary demonstrated atrophy of hepatic 
parenchyma and was very useful for classifying PHL.
Fig. 6. Case 1. Type V , left upper: plane CT, right upper: 
resected liver, left lower: schema, right lower: microscopic find-
ing (HE X 20)
 On the other hand, bile duct dilatation was accurately 
visualized by CT combined with DIC. As shown in case 2, 
such dilatation sometimes improved after complete removal 
of stones (Fig. 7). This finding was consistent with the 
report by Nimura5' that suspected stenosis disappeared, and 
suspected bile duct dilatation improved to the normal 
diameter following removal of intrahepatic stones. Since it 
was difficult to determine whether bile duct dilatation is 
reversible or not, it was excluded from indications for 
hepatectomy.
Fig. 7. Case 2. Type II
 The results of our treatment based on the above treat-
ment criteria are shown in Table 3. Postoperative cholan-
gitis was observe only in 1 patient. In addition, stones did 
not recur during the orservation period (maximum, 79 
months) in any patient. 
 These results suggest that our classification of PHL is 
very useful for determining therapeutic approches. How-
ever, malignant tumors in the biliary tract have been re-
ported to often complicate intrahepatic stones." In this 
series, malignant tumors (gallbladder cancer and bile duct 
cancer) were also observed in 3 patients. The possible 
presence of malignant trmors should be taken into consid-
eration during observation of clinical course.
the association of malignant lesions during the follow-up of 
this disease. 
 (An abstract of this paper was presented in the 3rd 
meeting of the World Association of the Hepatic, Pan-
creatic and Biliary Surgery.)
V. Conclusion 
One hundred twenty one patients with PHL were classified 
into five types, detecting by CT according to the mor-
phology of the liver, especially liver atrophy, and dicussed 
appropriate treatment methods for each PHL type. 
  In Type I, most of these patient were asymptomatic and 
they should not treated but just followed, since neither APH 
nor DIHBD were observed. In Type II, APH was not 
found, and they should be treated by liver-preserving 
operation, since improvement of liver function could be 
expected by removal stones and bile stasis. 
  In type III, IV, or V showing liver atrophy, hepatectomy 
should be primarily performed. 
  It was sugested, therefore, that the present classification 
of PHL was helpful in determining therapeutic strategy for 
PHL, although careful attention should always be paid to
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